Embryo implantation into receptive endometrium requires synergistic endometrial-blastocyst interactions within the uterine cavity and is essential for establishing pregnancy. We demonstrate that exosomes (40-150 nm nanovesicles) released from endometrial epithelial cells are an important component of these interactions. We defined the proteome of purified endometrial epithelial-derived exosomes (Exos) influenced by menstrual cycle hormones estrogen (E; proliferative phase) and estrogen plus progesterone (EP; receptive phase) and examined their potential to modify trophoblast function. E-/EP-Exos were uniquely enriched with 254 and 126 proteins, respectively, with 35% newly identified proteins not previously reported in exosome databases. Importantly, EP-Exos protein cargo was related to fundamental changes in implantation: adhesion, migration, invasion, and extracellular matrix remodeling. These findings from hormonally treated ECC1 endometrial cancer cells were validated in human primary uterine epithelial cell-derived exosomes. Functionally, exosomes were internalized by human trophoblast cells and enhanced their adhesive capacity, a response mediated partially through active focal adhesion kinase (FAK) signaling. Thus, exosomes contribute to the endometrialembryo interactions within the human uterine microenvironment essential for successful implantation.
INTRODUCTION
Initiation of human pregnancy requires synergistic interaction between the endometrium and the blastocyst, both immediately prior to and during implantation [1, 2] . The endometrium is a complex dynamic tissue that undergoes cyclical remodeling and differentiation throughout a women's reproductive life. Each menstrual cycle consists of proliferative (nonreceptive) and secretory (receptive) phases, regulated by the steroid hormones estrogen (E) and progesterone (P), respectively. The development of the endometrium that is receptive to embryo implantation occurs during the midsecretory phase of the menstrual cycle and depends upon adequate secretory transformation of the E-primed endometrium in response to P [3] [4] [5] . This transformation facilitates cellular and molecular regulation of cell-cell communication, cytoskeletal/extracellular matrix (ECM) remodeling, adhesion responses, and expression of many growth factors, cytokines, and their mediators [1, 6, 7] . Implantation takes place within the microenvironment of the uterine cavity. The embryo enters this cavity as an unhatched blastocyst where it undergoes hatching and final preparation for implantation. This involves a series of steps: apposition, adhesion, and invasion ( Fig. 1 ). In particular, the trophectoderm (destined to form the maternal component of the placenta) is modulated to enable endometrial attachment. Cell-cell communication between the trophectoderm and the endometrial epithelium are thus essential for embryo implantation and establishment of pregnancy.
Proteomic profiling of the endometrium has revealed many proteins important during various stages of the menstrual cycle [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Importantly, in terms of the peri-implantation microenvironment, secreted proteins of endometrial epithelial origin have been identified in uterine fluid or lavage samples during the receptive and nonreceptive phases of the cycle [11, 12] and importantly have defined functions in the embryo-maternal interaction [19] .
Exosomes, small extracellular vesicles (EVs) (40-150 nm) of endosomal origin, are released by many cell types, including endometrial epithelial cells, trophoblast cells and cancer cells [20] [21] [22] [23] [24] . Exosomes are known to play essential roles in cellcell communication [25] , cell transformation [26] , immune regulation [27] , and tumorigenesis [28] . Exosomal content has been shown to be diverse, consisting of proteins [21, 29] , different nucleic acids and transcripts [30, 31] , DNA [32] , lipids [33] , and metabolites [34] . More recently, exosomes have been identified in the follicular fluid of ovarian follicles, where they have been shown to contain diverse cell-derived microRNAs (miRNAs) and exosome-and cell-type-specific proteins, therefore suggesting a role in mediating cell communication within mammalian ovarian follicles and regulation of follicular maturation [35] [36] [37] . Trophoblast cells secrete exosomes to recruit and educate monocytes to initiate the pro-inflammatory microenvironment associated with early pregnancy [38] . Importantly, exosomes have been identified in the uterine microenvironment within human uterine fluid and have been shown to contain select miRNAs [24] .
Given their potential in modulating intercellular communication in a local microenvironment, this study investigated the contribution of exosomes during peri-implantation in regulating endometrial-embryo interactions throughout the uterine microenvironment. In particular, it focuses on the characterization of protein cargo of human endometrial epithelialderived exosomes in response to pregnancy hormones and its potential functions in embryo-maternal interactions. The data suggests that during pre-implantation, when the endometrium becomes receptive, specific exosomal cargo is packaged by the endometrial epithelium and delivered to trophoblast cells, enabling changes in their adhesive capacity to initiate successful implantation and hence establish a pregnancy.
MATERIALS AND METHODS

Endometrial and Primary Cell Isolation and Culture
ECC1, a human endometrial adenocarcinoma epithelial cell line [39] , were cultured and maintained in Dulbecco-modified Eagle medium nutrient mixture F-12 (DMEM/F-12) (Invitrogen-GIBCO) supplemented with 10% fetal calf serum (FCS) (Invitrogen-GIBCO) and 1% (v/v) penicillin/streptomycin (Pen/ Strep) (Invitrogen-GIBCO), and incubated at 378C with 5% CO 2 [21] . These ECC1 cells were validated by Karyotype analysis as in [39, 40] according to the ATCC guidelines [41] , with an allele match in the short tandem repeat profile of 100%.
Ethical approval was obtained for all human sample collections from Human Ethics Committees at Southern Health (no. 03066B) and Monash Surgical Private Hospital (no. 04056), and written informed consent was obtained from all the women. Primary endometrial epithelial cells (pEECs) were prepared from endometrial curettage as previously described [42] . Briefly, endometrial tissue was finely minced and digested in PBS (Invitrogen) solution containing DNAse (25 lg/ml; Roche) and collagenase type III (150 lg/ml; Sigma Aldrich) in a shaking water bath (130 rpm, 378C) for 20 min. Tissue digestion was stopped by adding DMEM/F12 (Invitrogen), and the tissue digest was vacuum-filtered through 45 and 11 lm filters. The pEECs were retrieved from the filters, centrifuged at 300 3 g for 5 min, resuspended in culture media (DMEM/F12) supplemented with 10% charcoal-stripped FCS and 1% Pen/ Strep (Invitrogen-GIBCO), and plated into 24-well plates for 2 days prior to hormonal treatment.
Hormonal Treatment of Endometrial Epithelial Cells (ECC1 and pEECs)
ECC1 cells, which most accurately resemble endometrial luminal epithelium [39, 43] , were grown under hormonal regimes that mimic the proliferative and secretory phases of the menstrual cycle. Limited numbers of pEECs were treated similarly. ECC1 cells (1 3 10 6 per 150 mm 3 culture dish, total of 120 dishes/replicate) ( Fig. 2) and/or pEECs (n ¼ 3, 80% confluence, grown in triplicate in 24-well plate) were washed three times with PBS and cultured for 24 h in serum-free DMEM/F12 supplemented with 0.5% insulintransferrin-selenium (ITS) solution (Invitrogen-GIBCO) and 1% (v/v) Pen/ Strep ( Fig. 2A) . After 24 h, the media were removed, replenished with serumfree media, and primed with 10
À8 M E (Sigma-Aldrich) for 24 h. Cells were divided into two groups and treated with 1) 10
À8 M E or with 2) 10 À8 M E plus 10 À7 M P (henceforth referred to as EP) (medroxyprogesterone-17-acetate; Sigma-Aldrich) ( Fig. 2A) . Conditioned culture media (CM) were collected at 24 and 48 h after hormonal treatments and used for isolating and purifying the exosomes (Fig. 2B) . The serum-free ECC1 culture conditions were initially optimized with assessment for cell morphology, proliferation, and viability.
Cell Morphology, Proliferation, and Viability Assays of ECC1 Cells
To ensure ECC1 cells retain the same morphology upon hormonal treatments, ECC1 cells (1.2 3 10 8 ) were grown in DMEM/F12 supplemented with 0.5% ITS in the presence of steroid hormones E or EP (as described) and imaged on an inverted Nikon Eclipse TE300 microscope equipped with a 103 objective (Nikon Plan Fluor) in phase-contrast mode using an attached 12.6mp digital camera (Nikon DXM1200C; Nikon Corporation). Images of ECC1 cells (10 independent fields of view, three biological replicates) were captured and processed with Nikon Elements Imaging Software (version 3.0, Nikon).
Cell viability of ECC1 cells was measured using the Trypan blue assay following 24 h culture in DMEM/F12 containing growth conditions as specified above. Viability was expressed as percentage of viable cells from total cells and presented as mean 6 SEM. The cell proliferation 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to FIG. 1. Roles of endometrial-derived exosomes during embryo implantation. The embryo enters the human uterus approximately 4 days after fertilization, generally as an unhatched blastocyst, where it further develops until it attaches to and invades the endometrial epithelium several days later. Soluble-secreted factors and exosomes (SS/Exos) are released by the endometrium into the uterine microenvironment and influence the blastocyst/ trophectoderm, enabling the blastocyst to undergo apposition, attachment, and invasion through the endometrial epithelium. GE, glandular epithelium; LE, luminal epithelium.
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determine ECC1 metabolic activity under different cell culture conditions. Briefly, ECC1 cells were subjected to different culture media with basal DMEM/F12 media and 1% Pen/Strep with the following conditions: 1) 10% FCS, 2) 1% ITS, 3) 1% ITS and 1% bovine serum albumin, 4) 0.5% ITS, and 5) 0.5% ITS and 0.5% bovine serum albumin with either no steroid hormones or with E or EP for 24 h. For the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays, measurements were performed in triplicate and expressed as relative absorbance (570 nm) for each condition.
FIG. 2.
Exosome isolation and purification from hormonally treated ECC1 cells. A) Experimental workflow for hormonal treatments of ECC1 cells and culture medium collection. B) Differential ultracentrifugation of culture medium for exosome isolation and purification. C) Western blot analysis of E-Exos and EP-Exos probed with exosome markers Alix and TSG101. D) Cryo-EM of purified exosomes revealing textured round vesicles (40-150 nm) . Bar ¼ 100 nm. CM, conditioned medium; ITS, insulin-transferrin-selenium.
EXOSOMAL IMPLANTATION REGULATION
Isolation of Crude Endometrial Exosomes
Conditioned medium of E-and EP-treated ECC1 cells were collected and centrifuged at 500 3 g for 5 min and 2000 3 g for 10 min to remove floating cells and cell debris, respectively. Large shed microvesicles was subsequently removed by centrifugation at 10 000 3 g for 30 min, followed by ultracentrifugation at 100 000 3 g for 1 h to isolate crude exosomes (Fig. 2B) [44, 45] . These exosomes will be referred to as E-Exos and EP-Exos, respectively.
Purification of Exosomes from ECC1 Cells Using OptiPrep Density Gradient
Briefly, a discontinuous iodixanol gradient was prepared by diluting a stock solution of OptiPrep-60% (w/v) aqueous iodixanol solution with 0.25 M sucrose and 10 mM Tris, pH 7.5-to generate 40% (w/v), 20% (w/v), 10% (w/ v), and 5% (w/v) iodixanol solutions, which were then layered sequentially by adding 3 ml each of 40%, 20%, and 10% solutions, and 2.5 ml of 5% iodixanol solution to a 14 3 89 mm polyallomer tube (Beckman Coulter). Crude exosomes (100 000 3 g pellet) were resuspended in 500 ll of 0.25 M sucrose and 10 mM Tris-HCl, pH 7.5, loaded on the top of the gradient and centrifuged at 100 000 3 g for 18 h at 48C. Twelve individual 1 ml fractions were collected (starting from the top of the gradient with increasing density), and each fraction was diluted with 2 ml PBS. After centrifugation at 100 000 3 g for 1 h at 48C, the supernatants were discarded and pellets washed with 1 ml PBS (100 000 3 g for 1 h at 48C) and resuspended in 50 ll of PBS. The density of each fraction was determined using a control OptiPrep gradient loaded with 500 ll of 0.25 M sucrose and 10 mM Tris, pH 7.5, run in parallel. Fractions were collected as described, serially diluted 1:10 000 with deuterated H 2 O, and iodixanol concentrations were estimated by absorbance at 244 nm using a molar extinction coefficient of 320 L g À1 cm À1 [46] . Purified exosomes were derived from two biological replicates for proteomic profiling and from two biological replicates for Western immunoblot analysis validation. Exosomes derived from pEECs were not purified using density-based fractionation because of insufficient primary material.
Exosomal Protein Quantification and Validation
Exosome pellets isolated from ECC1 and pEECs were quantified using onedimensional (1D) SDS-PAGE/SYPRO Ruby protein staining densitometry, as previously described [21, 45] . This method is sensitive, reproducible, has a linear quantitation range over three orders of magnitude [47] , and is compatible with gel electrophoresis liquid chromatography-tandem mass spectrometry (MS/MS) [48] . Densitometry quantitation was performed using ImageQuant software (Molecular Dynamics) to determine protein concentration relative to a BenchMark Protein Ladder standard of known protein concentration (1.7 lg/ll) (Life Technologies). In addition, Western blot analysis was used initially to determine exosome-containing fractions from the density gradient and subsequently to validate proteins identified by proteomic analysis in exosomes from both ECC1 and pEECs. Briefly, membranes (10 lg protein) were probed with primary antibodies-mouse anti-TSG101 (1:500 dilution; BD Transduction Laboratories), mouse anti-Alix (1:1000 dilution; Cell Signaling Technology), rabbit anti-GAPDH (1:1000 dilution; Cell Signaling Technology), goat anti-Collagen Type XV (1:200 dilution; Santa Cruz Biotechnology), rabbit antiLaminin a5 [H-160] (1:200 dilution; Santa Cruz Biotechnology), mouse anti-FAK (1:4000 dilution; BD Biosciences), mouse anti-FAK Tyr 397 (1:4000 dilution; BD Biosciences), rabbit anti-EpCAM (1:3000 dilution; Abcam), and rabbit anti-Fibronectin (1:1000 dilution; Abcam)-for 3 h at room temperature in 50 mM Tris, 150 mM NaCl, and 0.05% (v/v) Tween 20 followed by incubation with either IRDye 800 goat anti-mouse or anti-goat immunoglobulin G or IRDye 700 goat anti-rabbit immunoglobulin G (1:15 000 dilution; LI-COR Biosciences) for 1 h at room temperature in 50 mM Tris, 150 mM NaCl, and 0.05% (v/v) Tween 20. Immunoblots were visualized using the Odyssey Infrared Imaging System, (version 3.0; LI-COR Biosciences).
Cryo-Transmission Electron Microscopy
Cryo-transmission electron microscopy (cryo-EM) imaging of exosome preparations was performed as previously described [44, 45] with minor modifications. Briefly, exosomes (;2 lg protein, nonfrozen samples prepared within 2 days of analysis) were transferred to glow-discharged C-flat holey carbon grids (ProSciTech Pty Ltd). Excess liquid was removed by blotting, and the grids were plunge-frozen in liquid ethane. Grids were mounted in a Gatan cryoholder (Gatan, Inc.) in liquid nitrogen. Images were acquired at 300 kV using a Tecnai G2 F30 (FEI) in low-dose mode. Size distribution of vesicles (range 40-150 nm) was calculated for 15 fields of view/sample (n ¼ 2 biological replicates).
Proteomic Analysis
Exosome pellets (10 lg protein) for individual biological replicates of both E-Exos and EP-Exos were lysed in SDS sample buffer, electrophoresed by 4%-12% Bis-Tris SDS-PAGE (approximately 20 mm into the gel) and visualized by Imperial Protein Stain (Thermo Fisher Scientific). Individual samples were excised and destained in 50 mM ammonium bicarbonate/acetonitrile(ACN), reduced using 10 mM dithiothreitol (Calbiochem) for 30 min, alkylated using 50 mM iodoacetic acid (Fluka) for 30 min, and trypsinized using 0.6 lg trypsin (Promega sequencing grade) for 16 h at 378C as described previously [49] . For all the samples, peptides were desalted using reverse-phase C18 StageTips [50] and eluted in 85% (v/v) ACN in 0.5% (v/v) formic acid (FA). Peptides were lyophilized in a SpeedVac and acidified with buffer containing 0.1% FA and 2% ACN. A nanoflow UPLC instrument (Ultimate 3000 RSLCnano; Thermo Fisher Scientific) was coupled on-line to an Orbitrap Elite mass spectrometer (Thermo Fisher Scientific) with a nano-electrospray ion source (Thermo Fisher Scientific). Peptides (;2 lg) were loaded (Acclaim PepMap100 C18 5 lm 100 Å ; Thermo Fisher Scientific) and separated (Vydac MS C18-RP column, 25 cm, 75 lm inner diameter, 3 lm 300 Å ; Grace) with a 120-min linear gradient from 0%-100% of 0.1% (v/v) FA in 80% (v/v) ACN) at a flow rate of 250 nl/min.
The MS was operated in data-dependent mode where the top 20 most abundant precursor ions in the survey scan (300-2500 Th) were selected for MS/MS fragmentation. Survey scans were acquired at a resolution of 120 000 at m/z 400. Unassigned precursor ion charge states and singly charged species were rejected and peptide match disabled. The isolation window was set to 3 Th and fragmented by collision-induced dissociation with normalized collision energies of 25. Maximum ion injection times for the survey scan and MS/MS scans were 20 and 60 msec, respectively, and ion target values were set to 3E6 (3 3 10 6 ) and 1E6 (1 3 10 6 ), respectively. Selected sequenced ions were dynamically excluded for 30 sec. For each biological replicate of E-Exos and EP-Exos, technical replicates were performed and data acquired using Xcalibur software version 2.1 (Thermo Fisher Scientific). Raw mass spectrometry data is deposited in the PeptideAtlas and can be accessed online (http://www. peptideatlas.org/PASS/PASS00713) [51] [52] [53] .
Database Searching and Protein Identification
Raw data were processed using Proteome Discoverer (version 1.4.0.288; Thermo Fisher Scientific). MS2 spectra were searched with Mascot (version 1.4.0.288; Matrix Science), Sequest (version 1.4.0.288; Thermo Fisher Scientific), and X! Tandem (version 2010.12.01.1) against a database of 178 618 open reading frames (human plus bovine, 2015 06; UniProt). Peptide lists were generated from a tryptic digestion with up to two missed cleavages, carbamidomethylation of cysteine as fixed modifications, and oxidation of methionine and protein N-terminal acetylation as variable modifications. Precursor mass tolerance was 10 parts per million, product ions were searched at 0.6 Da tolerances, minimum peptide length defined at 6, maximum peptide length at 144, and maximum delta correlation of 0.05. Peptide spectral matches were validated using Percolator based on q-values at a 1% false discovery rate (FDR) [54, 55] . With Proteome Discoverer, peptide identifications were grouped into proteins according to the law of parsimony and filtered to 1% FDR [56] . Scaffold (version 4.3.4; Proteome Software Inc.) was employed to validate MS/MS-based peptide and protein identifications from database searching. Initial peptide identifications were accepted if they could be established at greater than 95% probability (posterior error probability 5%) as specified by the Peptide Prophet algorithm [57] . Protein probabilities were assigned by the Protein Prophet algorithm [56] . Protein identifications were accepted if they reached greater than 99% probability and contained at least two identified unique peptides. These identification criteria typically established ,1% FDR based on a decoy database search strategy at the protein level. Proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony. Contaminants, bovine identifications, and reverse identification were excluded from further data analysis. UniProt was used for protein annotation (molecular function and enzyme category), and KEGG (http://www.genome.jp/kegg/ pathway.html) and DAVID (http://david.abcc.ncifcrf.gov/) for pathway enrichment analyses. Comparisons with exosome database ExoCarta [58] were performed. This database contains curated exosomal protein information from diverse cell types and body fluids (June 2015, 146 studies).
Semiquantitative Label-Free Spectral Counting
Significant normalized spectral counts and their fold-change ratios (Rsc) were determined as previously described [21, 29, 44, 45] . The relative abundance of a protein within a sample was estimated using normalized spectral counts, where for each individual protein, significant peptide MS/MS spectra (i.e., ion score greater than identity score) were summated and GREENING ET AL.
normalized by the total number of significant MS/MS spectra identified in the sample. To compare relative protein abundance between samples, the ratio of normalized spectral counts (Rsc, fold change) was estimated. Total number of spectra was only counted for significant identified peptides (ion score ! homology score). When the Rsc is less than 1, the negative inverse value was used. The number of significant assigned spectra for each protein was used to determine protein expression differences. For each protein, the Fisher exact test was applied to significant assigned spectra. The resulting P-values were corrected for multiple testing using the Benjamini-Hochberg procedure [59] , and the statistics performed as previously described [44] .
Exosome Labeling and Live Cell Uptake E-Exos and EP-Exos purified from ECC1 cells (500 lg/ml) were labeled with 1 lM Vybrant DiI or DiD lipophilic dye (Invitrogen-GIBCO) and incubated at 378C for 10 min. Excess dye was removed by washing with PBS and ultracentrifugation at 100 000 3 g for 70 min at 48C. The DiI-or DiDlabeled exosomes were resuspended in 0.2 ml PBS and overlaid on a 4 ml 30% sucrose cushion (300 g/L sucrose and 24 g/L Tris base, pH 7.4) and ultracentrifuged at 100 000 3 g, for 70 min at 48C. Labeled exosomes were harvested at the PBS-sucrose interface and pelleted and stored at À808C (maximum of 4 wk) for downstream experiments, including uptake assays.
First-trimester human HTR8 trophoblast cells (2 3 10 5 ) [60] were plated in 8-well Ibidi chamber slides (Ibidi) and cultured for 24 h prior to live cell imaging using a DeltaVision Widefield microscope (GE Life Sciences) with a 603 1.42 NA objective using Optical Axis Integration scans over a z-range of 10 lm. A single plane brightfield image was recorded as the reference point. DiI-labeled exosomes (10 lg) were added immediately prior to image acquisition for 4 h with individual images obtained every 10 min. Three different positions were recorded per well with three sample repeats for each biological condition. Image processing and analysis were performed using Imaris (Bitplane AG). For DiI-labeled exosome uptake quantification, mean DiI fluorescence intensity was determined per time point and field-of-view and normalized to the respective mean autofluorescence intensity in the green channel to compensate for cells moving in and out of the field of view during the time course. Normalized fluorescence intensities are presented as mean 6 SEM. To obtain 3D images of exosome accumulation within HTR8 cells, DiD-labeled exosomes were added to HTR8 cells and incubated at 378C for 4 h, followed by addition of wheat germ agglutinin (WGA) Alexa594 as a red fluorescent membrane marker (2.5 lg/ml; Life Technologies) and incubated at 378C for 6 min. Cells were replenished with new media, and z-stack images were immediately recorded using a z-step size of 0.5 lm. For image visualization, 3D data sets were deconvolved using SoftWoRx (Applied Precision, GE Healthcare) and displayed as maximum intensity projections in xy/xz/yz planes. For z-stack image presentation and visualization, WGA is displayed in green and DiD in red.
Exosome Functional Real-Time Adhesion Assay
Adhesion assays were performed using the xCELLigence system (ACEA Biosciences). This system enables real-time measurement of cell adhesion based on cell interaction with microplate electrodes, resulting in electrical impedance, expressed as cell index (CI). Adhesion of cells was monitored every 15 sec for 4 h via the incorporated sensor electrodes, which measure the change in impedance caused by cell attachment and spreading. To initiate the experiment, a background reading of the microplate was taken as the threshold CI. HTR8 cells (2 3 10 4 ) were added to each well of an E-Plate 96 microplate (ACEA Biosciences) in the presence or absence of E-Exos or EP-Exos (50 lg/ ml, each in triplicate) and cell adhesion was measured. Data were evaluated using RTCA-integrated software, normalizing each data point on the CI obtained at the last time point of adhesion to background CI prior to adding HTR8 cells and exosomes. Data are presented as relative CI over a 4 h recording as mean 6 SEM (n ¼ 3 biological analyses).
Exosome Coculture and Cell Lysate Preparation
To define the effect of ECC1-derived exosomes in response to hormonal treatment on human HTR8, trophoblasts cells (2 3 10 5 , 6-well plate) were cultured either without exosomes (control) or with E-Exos or EP-Exos (50 lg/ ml, each in triplicate) for 24 h. Following incubation, the cells were washed with ice-cold PBS and lysed on ice with SDS sample buffer, that is, 4% (w/v) SDS, 20% (v/v) glycerol, 0.01% (v/v) bromophenol blue, and 0.125 M TrisHCl, pH 6.8. Lysates were subjected to ultracentrifugation for 30 min (386 000 3 g, TLA-100 rotor; Beckman Coulter), and the supernatants were aspirated for quantitation. Cellular lysates (15 lg) were separated by SDS-PAGE, transferred onto nitrocellulose membranes, and monitored by Western blots. Densitometric analysis was carried out using Image Studio (version 5; LI-COR Biosciences) and normalized by the loading control (GAPDH). Independent exosome coculture experiments were performed in biological triplicate, each with technical triplicate, and the results expressed as mean 6 SEM for individual experiments.
Statistical Analysis
Statistical analyses were performed to assess differences in adhesion response of HTR8 cells treated with exosomes (E-Exos or EP-Exos) or without exosomes over 4 h. Analysis of variance (ANOVA) and Tukey post hoc testing was applied to all the experimental conditions between the treatment groups and mock control. Student t-test was used when two groups were compared. All the analyses were calculated using GraphPad Prism (version 6.05) software. Unless otherwise stated, data are presented as mean 6 SEM (n ¼ 3 biological replicates, 3 technical replicates), with *P , 0.05 and **P , 0.01 considered statistically significant.
RESULTS
Exosomal research has grown exponentially in recent years, and although endometrial exosomes have been identified in the uterine cavity of women [24] , it is unknown whether they are hormonally regulated to influence the developing blastocyst and initiate implantation. The human ECC1 cell line, which most accurately represents luminal epithelial cells, were treated with E or EP, and the CM was used to isolate and purify exosomes (E-Exos and EP-Exos) and to characterize their protein cargo (Fig. 2, A and B) . To test the ECC1 cell line culture conditions prior to exosome isolation, cell morphology, viability, and proliferation were examined in the presence of menstrual cycle hormones (E, 10 À8 M, and P, 10 À7 M). E-Exos yielded 64 lg crude exosomes/10 6 cells and EP-Exos yielded 58 lg crude exosomes/10 6 cells (values from one representative result of three similar biological replicates), suggesting that exosomes were released in numbers independent of hormonal regulation. ECC1 cells exhibited and retained their epitheliallike morphology despite hormonal treatment (Supplemental Fig. S1 ; Supplemental Data are available online at www. biolreprod.org). Additionally, cell viability and proliferation (Supplemental Figs. S2 and S3) and protein yield (Supplemental Fig. S4) were not affected by either E or EP treatments. Consequently, culture medium supplemented with 0.5% ITS was used to culture ECC1 cells in the presence of hormonal treatments for subsequent exosome isolation ( Fig. 2A) .
Validation of Exosomes Isolated from ECC1 and pEECs
An OptiPrep density gradient was used to further purify EExos and EP-Exos. This purification showed that exosomes were enriched within fraction 7/8 (buoyant density 1.09-1.11 g/ml) and were positive for exosomal markers Alix and TSG101 (Fig. 2C) . To ensure exosomes were within the expected EV size range, cryo-EM was used to analyze purified E-Exos and EP-Exos. Cryo-EM revealed that both E-Exos and EP-Exos contained a relatively homogenous population of round membranous vesicles 40-150 nm in size (representative of 15 fields of view from two biological replicates), which is in accordance with the typical size reported for exosomes (Fig.  2D) [44, 45, 61] . Importantly, almost all the vesicles in both Eand EP-treated samples were less than 150 nm.
Hormonal Treatment Reprograms Endometrial-Derived Exosome Cargo
Proteomic profiling was performed to characterize the protein cargo of hormonally regulated endometrial-derived purified exosomes (Fig. 3A) . A total of 1043 protein cargos were identified, consisting of 917 and 789 in E-Exos and EP-EXOSOMAL IMPLANTATION REGULATION Exos, respectively ( Fig. 3B and Supplemental Table S1 ). From this analysis, 254 protein cargos were uniquely packaged within E-Exos while 126 were within EP-Exos. Of the 663 proteins common to both E-Exos and EP-Exos, many are involved in exosome biogenesis, including proteins involved in the endosomal-sorting complex required for transport (ESCRT) machinery such as the vacuolar protein sorting-associated protein family and tetraspanin (Table 1) . Protein cargos required for exosome sorting, trafficking, release, recognition, and uptake were found in both E-Exos and EP-Exos (Table 1) , a feature common to all exosomes in other tissues and biofluids [62] . Based on normalized spectral count ratios (i.e., Rsc), our dataset showed a range of relative differential protein expression levels that were up-and down-regulated in response to EP (Fig. 3C) .
Further analysis and comparison of this dataset with that of a publicly available exosomal database, ExoCarta [58] , revealed that 71% (473/663 proteins) of the cargo was found in common with previously reported exosome-associated proteins. Importantly, 190 of the 663 proteins from this study were unique to endometrial epithelial exosomes and have not been identified in any published exosome proteomic databases (Supplemental Table S2 ). We also identified several important enzyme proteins within exosomes, including various ligases, oxidoreductases, transferases, lyases, isomerases, phosphatases, kinases, metalloproteinases, and hydrolases (Supplemental Table S3 ), representing an extensive identification of various differentially expressed enzymes (fold change of 61.5) important for embryonic development and implantation.
Regulation of Proteins Associated with Cytoskeletal Reorganization and Signaling in Exosomes in Response to E
Estrogen is known to play a key role in endometrial restoration following menstruation. We examined exosome protein cargo in response to E, and noted key differences attributed to cytoskeletal reorganization, microtubule/actin networks, and various signaling cascades involved in regulating cytoskeletal rearrangements, cell migration, cell adhesion, and cell spreading (Supplemental Table S1 ). Cytoskeletal elements [63] , including microtubule network (TUBA1C, TUBA4A, PAFAH1B1, DCTN1), actin network (ARPC2, CALD1), actin-myosin binding (CDM), and actin cytoskeleton reorganization (CDK5, CDK2, RAP2A), were uniquely enriched in E-Exos. Of particular interest, were proteins involved in cytoskeletal reorganization, adhesion, and cell signaling, including Abl interactor 1 (ABI1), Ras-related protein Rap-2a (RAP2A), and MAP kinase 1 (MAPK1).
Regulation of Proteins Associated with Organization of ECM Architecture in Exosomes in Response to EP
Proteins identified in exosomes in response to EP treatment have significantly enriched functions attributed to cell adhesion, attachment, migration, and organization of ECM architecture, in accord with physiological changes in both the endometrium and the blastocyst during the secretory phase of the cycle (Table 2 ). These include the basement membrane molecules, member of the laminin family (Rsc range from 6.1 to 20.7), the collagen family (Rsc range 3.6 to 8.0), and cell adhesion and migration components ( Table 2 ).
Given that members of the laminin and collagen family were prominently displayed as protein cargo, LAMA5 and COL15A1 were selected for validation. Representative immunoblotting of E-Exos and EP-Exos showed the expression of both LAMA5 and COL15A1 as components of the protein cargo (Fig. 4A) . The intensity of the bands for laminin and collagen was stronger in EP-Exos compared to E-Exos samples in accordance with spectral counts from proteomic profiling ( Table 2) and reflected in densitometric analysis of the Western blots (Fig. 4A) . To ensure that the finding was true and consistent, the presence of LAMA5 and COL15A1 were also validated using exosomes derived from pEECs treated with E and EP (Fig. 4B) . Both exosomal proteins were elevated when the cells of origin had been exposed to EP. As expected, the pEEC exosomes also packaged both LAMA5 and COL15A1, more prominently in EP-pEECs, validating the findings from the cell line used. Densitometric analysis of the bands also indicated a higher level of LAMA5 in EP-Exos derived from ECC1 cells compared to pEECs. 
FIG. 3. Proteomic profiling of hormonally treated ECC1 cell-derived exosomes. A) Biological replicates of E-and EP-treated ECC1 purified exosomes separated by 1D SDS-PAGE (10 lg).
Individual gel slices were excised, and subjected further processing and analysis as shown. B) Two-way Venn diagram of E-and EP-treated exosomes. C) Normalized differential protein expression (Rsc, ratio of spectral counts) ranked as maximal difference between EP-Exos and E-Exos (fold-change . 2, P , 0.05). 
Exosomes Enriched for Molecules Involved in Embryo Implantation
In a comparative analysis of our current dataset to that of published studies on proteins essential for embryo implantation [5, 10, 13, 24, 43, 64, 65] , we found at least 14 proteins of interest (Table 3 ). These are unique and selective for exosomal vesicles and are packaged predominantly in EP-Exos samples representing in vivo P regulation during the endometrial receptive phase (Table 3) . Of interest to the developmental progress of pregnancy is our identification of complement decay-accelerating factor (CD55, Rsc of 7.1), perlecan (HSPG2, Rsc of 5.9), and EGFR (Rsc of 5.1) as intrinsic to exosomal protein cargo. These molecules are highly regulated at the time of blastocyst apposition and attachment [66] [67] [68] [69] [70] [71] [72] [73] .
Insights into Embryo Development: View from CancerAssociated Proteins in Exosomes
Embryo implantation and placental development use similar cellular mechanisms to that of cancer cells to migrate and invade [74] . We therefore compared our dataset with those proteins derived from quite different cancer exosomes and identified 23 common proteins (Supplemental Table S4 ). These proteins included members of the Wnt pathway, cell surface receptors EGFR, ECM proteins, tenascin, and matrix metalloproteinases.
Endometrial Exosomes Are Internalized by HTR8 Trophoblast Cells In Vitro and Enhance Their Adhesive Capacity
The functional activity of endometrial-derived exosomes was investigated using fluorescently labeled E-Exos and EPExos that were added to HTR8 trophoblast cells and monitored using live cell imaging. Real-time recording showed accumulation of exosomes occurring over a 4 h period with significant increase in fluorescence intensity seen in HTR8 trophoblast cells exposed to EP-Exos and E-Exos compared to mock control from 2.5 to 4 h (Fig. 5A) . Microscopy images confirmed cellular uptake and accumulation of E-Exos and EP-Exos in trophoblast cells (Fig. 5B) ; however, there was no difference in the level of fluorescence intensity between the two. Three-dimensional microscopy and visualization highlighted the colocalization of exosomes inside HTR8 cells with E-Exos (Fig. 5C ) and EP-Exos (Fig. 5D) .
To investigate whether exosomes transport functionally active cargo, the adhesive capacity of HTR8 cells was examined in the absence or presence of E-Exos and EP-Exos. Adhesion was monitored by the xCELLigence system and showed that EP-Exos induced a very rapid increase (by 1 h) in the adhesive capacity of HTR8 cells, reaching a maximum at 1.5 h and then being maintained until 4 h (experimental endpoint). This increased adhesion was significantly greater following uptake of EP-Exos (P , 0.001) compared to EExos. However, both exosome preparations significantly stimulated adhesion (P , 0.001) compared with cells not exposed to exosomes (Fig. 5E ). The EP-Exos are representative of the physiological condition at the time of implantation, and this stimulation of HTR8 adhesion is in accord with the proteomic data on their adhesion molecule content (Table 2) .
To determine a possible pathway leading to adhesion response in HTR8 cells following coculture with exosomes, selected adhesion markers, including focal adhesion kinase (FAK), phosphorylated FAK (Tyr 397 ), fibronectin, and EpCAM, were analyzed (Fig. 5, F and G, and Supplemental 
DISCUSSION
This study demonstrated that the cargo contained within human endometrial epithelial exosomes is hormonally regulated in accord with the phases of the menstrual cycle and that these exosomes can be taken up and release this cargo to functionally enhance trophoblast adhesive capacity during implantation. The findings provide key insights into endometrial-embryos communication during pre-implantation events, offering new understanding to these processes.
This study has utilized a comprehensive exosome isolation, purification, and characterization strategy to address the issue of vesicle heterogeneity. Vesicle annotation is an ongoing problem that has plagued the field over the past decade with varying categories and names describing the different EV subtypes, and this polemic has led to international efforts to standardize nomenclature and the quest for specific protein markers to distinguish one EV subtype from another [75] . For a position paper on standardization procedures for EV purification, see Witwer et al. [76] . As such, we have characterized exosomes in this study based on their specific buoyant density, marker proteins Alix and TSG101, vesicle diameter using cryo-EM, in addition to their protein cargo using proteomic profiling.
Our proteomic profiling of E-Exos and EP-Exos has identified and confirmed that exosomes contain basic machin- GREENING ET AL.
ery important to their biogenesis, trafficking, and release, supporting our previous reports [21, 29] . Of interest, this study presents a new set of protein cargo that is unique to human endometrial epithelial exosomes, which has not previously been reported in any studies. Enrichment of exosomes cargo was validated in both ECC1 cells and pEECs, supporting the experimental design and appropriate selection of cell models. ECC1-derived and primary cell-derived exosome cargo are similarly regulated by E and P, with significant enrichment of components associated with cell-matrix and adhesion during the hormonal equivalent of the receptive phase for implantation. It should also be noted that select protein vesicular cargo could be released by both luminal and glandular epithelial cells obtained from primary tissue. Thus, further characterization of such cargo is warranted to confirm protein validity between cell line-derived and primary-derived material. However, given that endometrial exosomal research is still in its infancy, this report represents the only definitive exosome protein cargo resource to date in the context of receptivity and embryonic implantation. The cargo identified in this present study highlights some key proteins found in higher amounts in EP-Exos compared to E-Exos and may have a specific role in embryo implantation. These are fibulin1 (FBLN1, Rsc 8.9), cysteine-rich 61 LGALS3BP
LGALS1 , and cytoskeletal components LAMA5 and COL15A1 for ECC1 cell-derived exosomes (n ¼ 2, E-Exos and EP-Exos, 10 lg; A) and pEEC-derived exosomes (n ¼ 3, E-Exos and EP-Exos; B). Densitometric analysis was performed using ImageJ version 1.44, showing mean 6 SEM with **P , 0.01 considered statistically significant. Table S1 .
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(CYR61, Rsc 7.0), complement decay-accelerating factor (CD55, 7.0), heparan sulfate proteoglycan 2 (HSPG2, Rsc 5.9). Fibulin-1 (FBLN1), a secreted glycoprotein associated with ECM remodeling, cell adhesion, and migration, and basement membrane interaction [77] , is 8.9 fold higher in EPExos compared to E-Exos. Because fibulin-1 has been shown to be highly regulated during the differentiation stage of the menstrual cycle, implantation, and pregnancy [78] , this finding further validates our data and suggests that fibulin-1 could be a key molecule involved in embryo implantation. HSPG2 and CD55 are both essential for embryo implantation. Previous studies [68, 79] demonstrated that the presence of HSPG2 in Representative real-time measurements of HTR8 cell adhesion over 4 h in absence (black) and presence of E-Exos (dark gray) and EP-Exos (gray) using xCELLigence RTCA instrument. Representative data is presented as mean 6 SEM, n ¼ 3, showing normalized fluorescence intensity (A) or relative CI (E). *P , 0.005, **P , 0.001, ***P , 0.0001 are considered statistically significant. F) Western blots of downstream target proteins (FAK, phosphorylated FAK, fibronectin, and EpCAM) in HTR8 cells after 4 h cultured with (50 lg/ml) or without E-Exos or EP-Exos. G) Densitometric analyses of normalized Western blots in F. Data is presented as relative intensity (mean 6 SEM, n ¼ 3 biological replicate) for each time point and target protein; *P , 0.05, **P , 0.01 are considered significant.
EXOSOMAL IMPLANTATION REGULATION
uterine epithelium facilitate trophoblast attachment and adhesion. CD55 has been shown to have high gene and protein levels during the window of implantation [80, 81] , and our data indicates that CD55 is being packaged in endometrial exosomes; this indicates its specificity and is worthy of further investigation. The presence of cysteine-rich 61 (CYR61 Rsc 7.1) maximally in EP-Exos suggests its importance. CYR61 is known to be found in trophoblasts during placental development where it appears to promote uterine vessel growth toward the embryo [82] . Furthermore, a global differential gene expression analysis of luminal epithelium at mouse implantation sites revealed that the CYR61 gene is up-regulated at the early-phase implantation site, specifically during embryo attachment but not in interimplantation sites and or under delayed implantation, suggesting a direct role in mediating embryonic-uterine signaling [83] . Collectively, these data suggest that CYR61 is present in luminal epithelium both at the gene and protein level and released into the implantation microenvironment in exosomes, suggesting possible involvement in endometrial-embryo cross talk by this route.
On further analysis of our dataset, we observed an increase in exosomal protein components in response to EP that are important in cell-adhesion and cell-cell signaling activity. These include the receptor proteins CELSR2 (Rsc of 5.1), adhesion receptor CD47 (Rsc of 4.1), CLDN3 (Rsc of 4.1), and PARVA (Rsc of 1.7), all of which are implicated in cell polarity. Additionally, ADAMTS15 (Rsc of 6.1) and ADAM10 (Rsc of 1.4) have proteolytic activity and may regulate the adhesion response [84] . Further, we report enriched expression of ANPEP (Rsc of 1.4) and DPP3 (Rsc of 1.4) in EP-Exos. ANPEP is associated with proteolytic cleavage during angiogenesis and has been suggested to modify the endometrial microenvironment [85] .
Members of the integrin family are essential for endometrium-embryo communication and implantation [86] [87] [88] . Endometrial exosomes contain a number of integrins with differential sorting in response to both E and P. These integrins include ITGA6 (Rsc of 1.5), ITGB1 (Rsc of 1.4), ITGB4 (Rsc of 1.3), ITGB3 (Rsc of À3.4), and ITGA2 (Rsc of À2.8). This is line with previous studies suggesting that integrin expression is hormone dependent [87] . The present study provides new knowledge that several members of the integrin family are selectively packaged within endometrial exosomes. They may be important for exosome docking to recipient cells, about which very little is known, or they may be released intracellularly to relocate to the cell surface and mediate trophoblast adhesion by interacting with ligands, including fibronectin and laminins [89, 90] . Certainly, microvesicles, of which exosomes are the smallest, are known to contain functional membrane proteins associated with membrane lipid rafts (such as tissue factor and chemokines receptor CCR5) that are subsequently incorporated into membranes of other cells [91, 92] .
The common protein cargos identified between E-Exos and EP-Exos are mostly involved in vesicle trafficking, sorting, release, and ECM reorganization. These are IST1, SNX6, and CDK1, where IST1 acts a key modulator of cargo protein sorting [93, 94] . Sorting nexin-6 (SNX6) is involved in intracellular vesicle trafficking and plays a key transport link between cytoplasmic transport vesicles and dynactin. Cyclindependent kinase 1 (CDK1) is a key mitotic kinase important for cell cycling and regeneration of proliferative phase endometrium and for embryonic survival at the pre-implantation stage [95] . ABI1 is another protein cargo involved in cytoskeletal reorganization and interacts with the EGFRsignaling pathway to regulate cell motility and proliferation [96, 97] . Endosomal-derived RAP2A GTPase is part of several signaling cascades thought to regulate cytoskeletal rearrangements, cell migration, adhesion, and invasion by up-regulating p-Akt [98, 99] . MAPK1 is a serine/threonine kinase that mediates cell adhesion, proliferation, cell cycle progression, cell survival, and transcription [100] . The identification of these molecules in our exosomes highlights the dynamic signaling pathways within the uterine microenvironment in preparation for embryo implantation and development.
In contrast, a number of factors with adhesion-related properties, including galectins (Gal-1, Rsc of À2.8, and Gal-3, Rsc of À3.4), were identified at reduced concentrations in exosomes in response to EP. Galectins bind galactosides and have differing roles, including cell-adhesion and invasion of trophoblast and regulation of endometrial receptivity [101, 102] . Recently Gal-1 has been shown to influence trophoblast immune evasion, regulating human leukocyte antigen G on expression on trophoblast cells [101] . Both Gal-1 and Gal-3 contribute to the organization of ECM and the regulation of cell motility in first-trimester placental tissue and in cell cultures derived from placental and decidual tissue [103] .
Changes in adhesion of trophoblast have previously been functionally identified but without consideration of their control mechanisms [104, 105] . It is known that exosomes may selectively transfer certain proteins and other cargo to recipient cells resulting in selective downstream functional effects [106] [107] [108] . The present study demonstrated that exosomes derived from receptive phase endometrium in the context of peri-implantation can alter trophoblast behavior to favor the functional adhesive response needed for implantation. In addition, we demonstrated that this is mediated at least in part via the FAK pathway, as evident by an increase of FAK protein expression and phosphorylation of FAK (pTyr 397 ) [109] in trophoblast cells after 4 h coculture with endometrial exosomes (Fig. 5) . FAK is activated and localized at focal adhesions upon cell adhesion to the ECM through integrin binding, triggering phosphorylation of FAK-Tyr 397 [110] , thus implicating integrin binding among the actions of exosomal cargo on adhesion. However, given that these exosomes also contain specific miRNAs [24] and probably RNAs and lipids, further investigations are required to define precisely which components of the exosomal cargo are most important and how the fate of trophectodermal cells may be dictated by these cellspecific exosomes and their cargo.
At this time, although the biological effects of exosomal transfer can be profound, the mechanisms of exosome uptake by cells and how their protein cargo is utilized by cells are not known [111] . In addition, direct evidence for a causal relationship between specific exosomal molecular cargo and function is rare. Some studies have shown that cancer-derived exosomes have TGF-b1 at their surface and are tethered by its receptor betaglycan. However, their delivery requires an intact heparan sulfate side chain; this highlights a different form of vesicular transport to that of soluble forms [112] . TGFb1 is also responsible for controlling immune responses in cells to which it is delivered from vesicles [113, 114] . Exosomes also deliver mRNA that is subsequently translated to protein in recipient cells [31, 115] , and their miRNA cargo can regulate the recipient cell's transcriptome [116] [117] [118] . It is clear that the concept of premetastatic niche formation, whereby secreted signals and extracellular vesicles from both tumor and host cells can promote cancerous growth and metastasis [119] , can be applied to the preparation of the blastocyst for its landing on and subsequent invasion of the endometrium to establish pregnancy. Similarly, exosomes from one endometrial epithe-lial cell could act to prepare other endometrial cells in the vicinity for implantation, strongly highlighting the critical role of exosomes in cell-cell communications within the uterine microenvironment prior to embryo implantation and placentation.
This study has therefore provided a new insight into the regulation of human embryo implantation, demonstrating a contribution of endometrial-derived exosomes to endometrialembryo cross talk. The protein cargo of endometrial exosomes is substantially regulated by E and P, as physiologically relevant to the proliferative and secretory phases of the menstrual cycle, respectively. Importantly, endometrial exosomes contain a number of unique proteins not previously identified in exosomes from any other tissue, biofluid, or indeed cell model. Significantly, our study shows that endometrial exosomes within the extracellular microenvironment during the peri-implantation period are capable of regulating trophectodermal cell adhesiveness partially through active focal adhesion kinase (FAK) signaling. Endometrial exosomes may provide a means for improving pre-implantation embryo developmental potential and thus become targets for improving receptivity, implantation success, fertility, and pregnancy outcomes, hence reducing the considerable personal and financial cost of infertility.
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